Corticosteroids reduced mortality (only for severe CAP), reduced need for invasive mechanical ventilation (intubation) and ICU admission as well as length of hospital and ICU stay

Improved chance of favorable functional outcome (mRS 0–3) and functional independence (mRS 0–2); lower risk of death at 90 days; higher risk of symptomatic intracranial hemorrhage at 24–72 h compared to standard medical treatment

LMWH reduces thrombus size and major hemorrhagic events more than UFH in venous thromboembolism